
One of a novel series of compounds zzso or zzso zzso has shown significant zzso activity in in zzso and in in zzso tumor systems, but has less animal zzso toxicity than the lead compound in the same series zzso This study was designed to evaluate the zzso qualitative and quantitative zzso of zzso and to determine the recommended phase II dose zzso of zzso given as a short infusion daily for 3 days every 3 zzso zzso patients with zzso zzso received 79 courses over 9 dose levels during this zzso zzso ranged from 50 to zzso zzso zzso 3 zzso Due to the possibility of local zzso with zzso zzso zzso zzso drug was administered in solutions containing zzso or zzso zzso zzso Because large volumes were needed at the higher dose levels, the infusion duration was increased from 2 hours to 4 zzso zzso to moderate zzso zzso fatigue, zzso and headaches were zzso zzso was the dose limiting zzso The recommended phase II dose and schedule was determined to be 800 zzso zzso zzso every 3 zzso zzso plasma zzso data were analyzed using a zzso zzso zzso The zzso beta averaged 6 hours and the total body clearance was zzso zzso The volume of distribution zzso was large, averaging 470 zzso 

